BRT Sells to Medix Biochemica
BroadOak Capital Partners advised Bioresource Technology (“BRT”) on the sale of the company to Medix Biochemica. BRT is a leading provider of high-quality base matrices and other critical raw materials for the IVD industry. The full press release is below. Bioresource Technology joins Medix Biochemica Group Medix Biochemica broadens its capabilities in diagnostic base matrices […]